<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>In 2009, the Union for International <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">Cancer</z:e> Control issued the seventh edition of the well-used T (<z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e>), N (node), and M (<z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e>) classification guidelines </plain></SENT>
<SENT sid="1" pm="."><plain>There has been a continual refinement of the staging for <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> since this system for assessing <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> stage was initially adopted and it has been used to guide treatment decisions for over 50 years </plain></SENT>
<SENT sid="2" pm="."><plain>However, the outcome after therapy for patients with <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> is very variable, even when patients are assigned to the same TNM category </plain></SENT>
<SENT sid="3" pm="."><plain>This article assesses the changes that have been made since the sixth edition and discusses whether they are, in fact, informative improvements for a practicing clinician </plain></SENT>
</text></document>